期刊文献+

格列美脲蛋白结合作用的高效液相色谱迎头分析法 被引量:4

Liquid chromatography frontal analysis of the protein binding of glimepiride
在线阅读 下载PDF
导出
摘要 目的 研究格列美脲与人血清白蛋白(humanserumalbumin,HSA)结合作用。方法 采用高效液相色谱 迎头分析法(highperformanceliquidchromatography frontalanalysis, HPLC FA)。色谱柱为内表面反相(internal surfacereversed phase,ISRP)硅胶柱PinkertonGFFII S5 80(1.50mm×4 .6mmID, 5μm);流动相为 67mmol·L-1磷酸盐等渗缓冲液 (pH 7. 4, I=0 17mol·L-1 );流速 0 2mL·min-1;检测波长 230nm;进样量 900μL;柱温37℃。结果应用非线性回归参数估算求得HSA分子上两类结合位点结合的格列美脲分子数及相应的结合平衡常数:n1 =1和K1 =5. 1 (μmol·L-1 )-1;n2 =7和K2 =0. 017 (μmol·L-1 )-1。结论 HPLC FA法操作简便,适用于研究格列美脲与HSA的结合作用。 Aim To study the protein binding of glimepiride. Methods An HPLC-FA method is performed by using Pinkerton GFF II-S5-80 internal-surface reversed-phase silica support (150 mm×4.6 mm ID, 5 μm) at pH 7.4 in a 67 mmol·L-1 isotonic sodium phosphate buffer at 37 ℃. Other conditions included flow rate of 0.2 mL·min-1, UV detection at wavelength 230 nm and injection volume 900 μL. Results Nonlinear regression parameter estimation was used for the association constant measurement of glimepiride to both primary and secondary sites, which were 5.1 (μmol·L-1)-1 and 1 for K_1 and n_1, and 0.017 (μmol·L-1)-1 and 7 for K_2 and n_2, respectively. Conclusion The method is shown to be suitable for investigation of protein binding of glimepiride.
出处 《药学学报》 CAS CSCD 北大核心 2005年第1期39-42,共4页 Acta Pharmaceutica Sinica
关键词 格列美脲 高效液相色谱-迎头分析法 人血清白蛋白 蛋白结合作用 glimepiride high performance liquid chromatography-frontal analysis human serum albumin protein binding interaction
  • 相关文献

参考文献22

  • 1乔明曦,郭兴杰,李发美.高效迎头分析法测定药物-人血清白蛋白混合液中游离药物浓度[J].色谱,2001,19(4):329-331. 被引量:4
  • 2Wood GC, Cooper PF. The application of gel filtration to the study of protein-binding of small molecules [ J ].Chromatogr Rev, 1970,12( 1 ) :88 - 107.
  • 3Shibukawa A, Terakita A, He JY, et al. Highperformance frontal analysis-high-performance liquid chromatographic system for stereoselective determination of unbound ketoprofen enantiomers in plasma after direct sample injection [J]. J Pharm Sci, 1992,81(7):710 -715.
  • 4Shibukawa A, Ishizawa N, Kimura T, et al. Plasma protein binding study of oxybutynin by high-performance frontal analysis method [ J]. J Chromatogr B, 2002,768 (1) :177 -188.
  • 5Shibukawa A, Yoshikawa Y, Kimura T, et al. Binding study of desethyloxybutynin using high-performance frontal analysis method [J]. J Chromatogr B, 2002,768 (1) :189 -197.
  • 6ShibukawaA, Nakagawa T, Nishimura N, et al. Determination of free drug in protein binding equilibrium by high-performance frontal analysis using internal-surface reversed-phase silica support [ J ]. Chem Pharm Bull, 1989,37 (9) :702 - 706.
  • 7Qiao MX, Guo X J, Li FM. Chemiluminescence detection coupled to high-performance frontal analysis for the determination of unbound concentrations of drugs in protein binding equilibrium [ J]. J Chromatogr A, 2002, 952(1 -2) :131 - 138.
  • 8Li FM, Qiao MX, Guo XJ. Specific determination of unbound oxacillin in protein solution with cefoperazone by high-performance frontal analysis with chemiluminescence detection [J]. Biomed Chromatogr, 2003,17( 1 ) :53 - 57.
  • 9Shibukawa A, Kuroda Y, Nakagawa T. High performance frontal analysis for drug-protein binding study [J]. J Pharm Biomed Anal, 1999,18(6) :1047 - 1055.
  • 10Shibukawa A, Nakagawa T. Theoretical study of highperformance frontal analysis: a chromatographic method for determination of drug-protein interaction [ J ]. Anal Chem, 1996,68 (3) :447 - 454.

二级参考文献1

  • 1Shibukawa A,J Pharm Sci,1992年,81卷,7期,710页

共引文献3

同被引文献2189

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部